A Phase 2 clinical trial investigating the anti-virus effects, kinetics and safety of GS-5806 in adults with RSV (Respiratory Syncytial Virus) infection

Update Il y a 4 ans
Reference: EUCTR2014-002474-36

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the effect of GS-5806 on RSV viral load in RSV-positive autologous or allogeneic HCT recipients with acute URTI symptoms


Inclusion criteria

  • Respiratory Syncytial Virus (RSV) Infection of the upper respiratory tract